Acorda Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2010 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Acorda Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 27, 2024 was 1.24M shares, a 94.9% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.24M -23.1M -94.9% Mar 27, 2024 10-K/A 2024-04-29
Q3 2023 1.24M -23.1M -94.9% Nov 9, 2023 10-Q 2023-11-14
Q2 2023 1.24M -23M -94.9% Aug 4, 2023 10-Q 2023-08-09
Q1 2023 24.3M +11.1M +83.7% Mar 10, 2023 10-K 2023-03-15
Q3 2022 24.3M +13.1M +117% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 24.3M +13.2M +118% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 13.3M +3.76M +39.6% Mar 9, 2022 10-K 2022-03-18
Q3 2021 11.2M -36.8M -76.6% Nov 5, 2021 10-Q 2021-11-12
Q2 2021 11.1M -36.9M -76.8% Aug 6, 2021 10-Q 2021-08-12
Q1 2021 9.49M -38.5M -80.2% Mar 4, 2021 10-K 2021-03-16
Q3 2020 48M -67.8K -0.14% Oct 30, 2020 10-Q 2020-11-06
Q2 2020 48M -129K -0.27% Jul 31, 2020 10-Q 2020-08-07
Q1 2020 48M -145K -0.3% May 4, 2020 10-Q 2020-05-08
Q3 2019 48M +472K +0.99% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 48.1M +624K +1.32% Jul 31, 2019 10-Q 2019-08-07
Q1 2019 48.1M +1.06M +2.26% May 1, 2019 10-Q 2019-05-07
Q3 2018 47.6M +811K +1.74% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 47.5M +833K +1.79% Jul 31, 2018 10-Q 2018-08-08
Q1 2018 47.1M +407K +0.87% May 7, 2018 10-Q 2018-05-09
Q3 2017 46.7M +633K +1.37% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 46.7M +511K +1.11% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 46.7M +592K +1.29% Apr 30, 2017 10-Q 2017-05-09
Q3 2016 46.1M +2.96M +6.86% Oct 31, 2016 10-Q 2016-11-07
Q2 2016 46.1M +3.29M +7.69% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 46.1M +3.28M +7.66% Apr 30, 2016 10-Q 2016-05-06
Q3 2015 43.2M +1.21M +2.88% Oct 31, 2015 10-Q 2015-11-09
Q2 2015 42.8M +1.1M +2.64% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 42.8M +1.14M +2.75% Apr 30, 2015 10-Q 2015-05-08
Q3 2014 41.9M +673K +1.63% Oct 31, 2014 10-Q 2014-11-07
Q2 2014 41.7M +1.05M +2.58% Jul 31, 2014 10-Q 2014-08-07
Q1 2014 41.6M +1.08M +2.66% Apr 30, 2014 10-Q 2014-05-09
Q4 2013 41.3M Feb 14, 2014 10-K 2014-03-03
Q3 2013 41.3M +1.12M +2.78% Oct 31, 2013 10-Q 2013-11-07
Q2 2013 40.7M +600K +1.5% Jul 31, 2013 10-Q 2013-08-08
Q1 2013 40.6M +470K +1.17% Apr 30, 2013 10-Q 2013-05-10
Q3 2012 40.2M +490K +1.24% Oct 31, 2012 10-Q 2012-11-08
Q2 2012 40.1M +436K +1.1% Jul 31, 2012 10-Q 2012-08-08
Q1 2012 40.1M +995K +2.55% Apr 30, 2012 10-Q 2012-05-09
Q3 2011 39.7M +588K +1.5% Oct 31, 2011 10-Q 2011-11-07
Q2 2011 39.7M +782K +2.01% Jul 31, 2011 10-Q 2011-08-08
Q1 2011 39.1M Feb 17, 2011 10-Q 2011-05-09
Q3 2010 39.1M Oct 31, 2010 10-Q 2010-11-09
Q2 2010 38.9M Jul 31, 2010 10-Q 2010-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.